AN

ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş.

Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.

ANGEN | IS

Overview

Corporate Details

ISIN(s):
TREANGN00010 (+1 more)
LEI:
789000SFK2PSN72IVM96
Country:
Türkiye
Address:
İSTANBUL PLAZA KASAP İSMAİL SOK.NO.10/22-23, 34722 ISTANBUL
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anatolia Geneworks is a biotechnology company specializing in the research, development, and manufacturing of molecular diagnostic solutions. The company's core expertise lies in Real-Time PCR (qPCR) technology. Its primary product line, the Bosphore® series of qPCR kits, enables the rapid and accurate detection of various pathogens causing infectious diseases, including sexually transmitted diseases, sepsis, gastroenteritis, and hepatitis. To support diagnostic workflows, the company also develops and manufactures the UNIO® family of automated robotic systems for nucleic acid isolation and PCR setup. By providing both advanced diagnostic kits and integrated automation systems, Anatolia Geneworks offers a comprehensive solution for clinical and research laboratories worldwide, aiming to improve testing efficiency and diagnostic outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-30 17:14
Share Issue/Capital Change
Company General Info Form
English 7.3 KB
2025-09-30 17:13
Board/Management Information
Mali İşler Direktörünün Görevinden Ayrılması Hk.
English 17.0 KB
2025-09-09 17:10
Environmental & Social Information
Participation Finance Principles Information Form
English 53.1 KB
2025-09-08 17:10
Environmental & Social Information
Participation Finance Principles Information Form
English 53.1 KB
2025-08-19 12:04
Registration Form
Esas Sözleşme Hk.
Turkish 205.2 KB
2025-08-19 12:04
Registration Form
Esas Sözleşme Hk.
English 22.2 KB
2025-08-19 12:04
Registration Form
Kayıtlı Sermaye Tavanına İlişkin Esas Sözleşme Maddesi Tadilinin Tescili Hk.
Turkish 1.2 MB
2025-08-19 12:04
Share Issue/Capital Change
Kayıtlı Sermaye Tavanına İlişkin Esas Sözleşme Maddesi Tadilinin Tescili Hk.
English 6.6 KB
2025-08-19 12:01
Post-Annual General Meeting Information
Bağımsız Denetim Şirketinin Tescili Hk.
Turkish 28.9 KB
2025-08-19 12:01
Registration Form
2024 Yılı Olağan Genel Kurul Kararlarının Tescil Edilmesi Hk.
Turkish 1.2 MB
2025-08-19 12:01
Pre-Annual General Meeting Information
2024 Yılı Olağan Genel Kurul Kararlarının Tescil Edilmesi Hk.
Turkish 1.2 MB
2025-08-19 12:01
Pre-Annual General Meeting Information
2024 Yılı Olağan Genel Kurul Kararlarının Tescil Edilmesi Hk.
Turkish 308.0 KB
2025-08-19 12:01
Pre-Annual General Meeting Information
2024 Yılı Olağan Genel Kurul Kararlarının Tescil Edilmesi Hk.
Turkish 142.3 KB
2025-08-19 12:01
Post-Annual General Meeting Information
2024 Yılı Olağan Genel Kurul Kararlarının Tescil Edilmesi Hk.
Turkish 1.5 MB
2025-08-19 12:01
Post-Annual General Meeting Information
2024 Yılı Olağan Genel Kurul Kararlarının Tescil Edilmesi Hk.
Turkish 16.8 KB

Automate Your Workflow. Get a real-time feed of all ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ANATOLİA TANI VE BİYOTEKNOLOJİ ÜRÜNLERİ ARAŞTIRMA GELİŞTİRME SANAYİ VE TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan 4519
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden CINPHA
Circio Holding ASA Logo
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
Norway CRNA
CJ Bioscience Logo
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
South Korea 311690
CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea 063160
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea 058820
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany CNW
Compugen Ltd. Logo
Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.
Israel CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.
South Korea 166480
Corline Biomedical AB Logo
Develops heparin-based coatings for medical device biocompatibility and regenerative medicine.
Sweden CLBIO

Talk to a Data Expert

Have a question? We'll get back to you promptly.